An experimental Ebola vaccine similar to one being developed by GlaxoSmithKline is effective for at least five weeks in lab monkeys but requires boosting with an additional vaccine to extend its protection to 10 months, according to a study published on Sunday.
French company Carmat confirmed on Monday that it had fitted a second patient with one of its artificial hearts and would continue its clinical trials on two more patients.
Harvard University has received the largest donation in its history, the school announced on Monday: $350 million from the Morningside Foundation to the School of Public Health.
Hospitals are becoming safer for very sick children, according to a new study that found steep declines in dangerous infections sometimes transmitted through treatments in intensive care units.
Children's kidney and thyroid cancers have increased in recent years, and though the diseases are rare, experts wonder if the rising rates could be related to obesity.